Primary malignant HEH of the liver is a rare tumor with an incidence ... However, a rapidly fatal evolution is also possible. Differential diagnoses include metastatic adenocarcinoma, and various ...
BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...
Pedraza-Cruz, P. , Varghese, M. , DiGiacomo, D. , Spencer, C. and Horani, O. (2025) Adrenal Crisis Secondary to Bilateral Adrenal Hemorrhage in a Patient with Hypercoagulable Disorder. Case Reports in ...
Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...
Low-Level Traffic Air Pollution Linked to Liver Damage and Fatty Liver Disease Jan. 31, 2025 — Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic ...
Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...
2d
News Medical on MSNLiver injury in immune Stevens-Johnson Syndrome and toxic epidermal necrolysis: Five new classification typesFirst identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, from milder forms (SJS) to the most severe (TEN). SJS/TEN is associated with ...
Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
Non-alcoholic fatty liver disease (NAFLD) occurs when excess fat accumulates in liver cells in people who consume little or no alcohol. NAFLD is associated with various metabolic risk factors ...
Apr. 3, 2024 — A routine blood test that measures a patient's inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.
SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results